ArticleFrontiers in public health2021

Economic Evaluation of First-Line Atezolizumab for Extensive-Stage Small-Cell Lung Cancer in the US.

Yingcheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.